MAKO Surgical Corp was a medical device company that focused on developing and marketing robotic systems for orthopedic and urologic procedures.
The company was founded in 1997 in Tampa, Florida.
MAKO's flagship product was the MAKOplasty system, a robotic arm-assisted surgery system used for procedures such as total hip arthroplasty and partial knee resurfacing.
This system allowed surgeons to create customized implant plans for patients, resulting in faster recovery times and less pain.
Impact of Acquisition
Stryker's acquisition of MAKO Surgical for $1.65 billion was initially criticized as too expensive, but by 2019, Stryker felt justified in its purchase.
By 2019, Stryker had about 860 Mako robots installed globally.
Stryker's move into robotics began with its MAKO Surgical acquisition and has continued to develop with the 2021 acquisition of OrthoSensor, adding an intraoperative sensor technology to enhance Stryker's Mako robots.
In 2021, Stryker's strength in robotics was cited as one cause of its upward stock price.
See what others are reading: Surgical Tech
Equity research analyst Dave Keiser identifies Mako as the transformational acquisition in terms of Stryker getting on board with robotics before some of their competitors in the space.
By the end of 2020, about 44% of all Stryker's total knee replacement procedures were done with the Mako robot.
Stryker estimates that the adjusted earnings per share after the acquisition will be a decrease of $0.10 to $0.12 for the first year, neutral for the second year, and accretive after that.
The combination of Stryker's established industry leadership with MAKO's innovative products and people contains the power to positively transform orthopedics.
Company Details
MAKO Surgical Corp. was a medical device company that focused on developing and marketing robotic systems for orthopedic procedures.
The company was founded in 1997 by Dr. Maurice R. Fernandez and was based in Sunrise, Florida.
MAKO Surgical Corp. was acquired by Stryker Corporation in 2013 for approximately $1.65 billion.
A fresh viewpoint: Buy Post Surgical Bras
Products
MAKO Surgical Corp. markets the RIO Robotic Arm Interactive Orthopedic System and RESTORIS Family of Implants for partial knee and total hip arthroplasty, known as MAKOplasty.
MAKOplasty increases accuracy in aligning and placing implants, which is a significant improvement over traditional methods. This is achieved through the creation of a 3-D model of the patient's anatomy, allowing surgeons to develop a pre-surgical plan that customizes implant size, positioning, and alignment specifically for each patient.
The RIO system assists surgeons by providing real-time visual, tactile, and auditory feedback, enforcing a safety-zone and facilitating ideal implant positioning and placement. This reduces the potential for complications during the procedure.
MAKOplasty is offered in over 150 hospitals across the country, including notable institutions like the Hospital for Special Surgery in New York and the Mayo Clinic Hospital in Jacksonville, Florida.
Mako Total Knee was launched in 2017, combining Mako Robotic-Arm Assisted Technology with the Triathlon Total Knee System. This innovative technology aims to provide even better outcomes for patients undergoing knee replacement surgery.
Related reading: Which Part of Medicare Covers Inpatient Hospital Charges
Annual Revenue
MAKO Surgical Corp. had an annual revenue of $102.7 million in 2025.
How Many Employees?
MAKO Surgical Corp. has a relatively small workforce, with 85 people employed there.
Working at a smaller company can have its advantages, like a more personalized work environment.
85 employees is a manageable size for a company, allowing for more direct communication and collaboration.
This smaller staff also means that MAKO Surgical Corp. likely has a more streamlined organizational structure.
NaICS Code Meaning
Understanding NAICS Codes is a crucial part of researching a company.
A NAICS code is a specific number assigned to a business based on its industry and activities.
For example, MAKO Surgical Corp. has a NAICS code of 33, 339.
These codes help identify the type of business and can be used for various purposes, such as government contracting and tax purposes.
The NAICS code for MAKO Surgical Corp. is specifically 33, which falls under the category of "Construction" and 339, which falls under "Manufacturing".
Additional reading: Naics Code Bank
Key People
MAKO Surgical Corp. was founded by Fred Moll, who served as the company's Chairman of the Board and CEO.
Fred Moll is a renowned entrepreneur and inventor in the field of medical devices.
MAKO's Board of Directors included notable figures such as John K. Funkhouser and David A. Fasoli.
The company's leadership team also consisted of experienced professionals like Dr. John D. Sweeney and Dr. John G. Mason.
Fred Moll's vision for MAKO was to develop innovative surgical technologies that would improve patient outcomes and reduce recovery times.
A fresh viewpoint: Fred Ehrsam
Frequently Asked Questions
How much did Stryker pay for Mako?
Stryker paid $1.65 billion for MAKO Surgical in 2013. The acquisition price was initially questioned, but Stryker later deemed it a justified investment.
Featured Images: pexels.com
